Test Price
2,800 AED✅ Home Collection Available
HARS2 Gene Perrault Syndrome Type 2 Genetic Test in UAE | 2800 AED | 2026 DHA Guidelines
تحليل HARS2 Gene Perrault Syndrome Type 2 Genetic Test في الإمارات | 2800 درهم | معتمد من هيئة الصحة بدبي
الملخص التنفيذي
تحليل جيني متطور بدقة 99.9%، خدمة سحب منزلية معتمدة، واستشارة طبية بعد النتيجة – كل ذلك وفقًا لأعلى معايير هيئة الصحة بدبي.
Overview
The HARS2 Gene NGS Test identifies mutations associated with Perrault Syndrome Type 2, enabling accurate diagnosis and genetic counselling. يوفر هذا الاختبار تشخيصًا جينيًا دقيقًا للمساعدة في التخطيط الأسري واتخاذ القرارات الطبية.
| Parameter | Our Test (NGS – Next-Generation Sequencing) | Closest Alternative (Sanger Sequencing) |
|---|---|---|
| Precision/Method | Full gene coverage, detects known and novel variants; high-throughput NGS | Limited to pre‑defined mutations; lower discovery power |
| Turnaround Time | 3 to 4 weeks | 4 to 6 weeks |
| Diagnostic Sensitivity | > 99.9% (ISO 9001:2015 certified) | ~95% for targeted regions |
Physician Insight & Safety Protocol
Dr. PRABHAKAR REDDY (DHA License: 61713011) shares: “As a neurologist, I understand the emotional weight of genetic testing for rare syndromes. While this test offers clarity, results must be correlated with clinical findings. Remember, a negative result does not rule out other genetic causes, and a positive result should be discussed in a dedicated genetic counselling session.”
⚠️ Medication Warning: Do not discontinue prescribed medication without consulting your doctor. Genetic results are intended to support – not replace – your current treatment plan.
Exclusion Criteria & Emergency Red Flags
- Active acute infection or febrile illness – consider postponing non‑urgent genetic testing.
- Inability to provide informed consent (minors require legal guardian consent per UAE CDS Law 2026).
- If you experience sudden severe hearing loss, acute abdominal pain, or seizures, seek emergency care immediately – this test is not a substitute for urgent medical evaluation.
- This test is not designed for prenatal diagnosis without prior genetic counselling.
Patient FAQ & Clinical Guidance
1. What is the HARS2 Gene Perrault Syndrome Type 2 NGS Test and why is it performed?
This next-generation sequencing test examines HARS2 gene mutations causing Perrault syndrome type 2, a condition involving hearing loss. يُستخدم للكشف عن الطفرات الجينية المسببة لمتلازمة بيرو النوع الثاني، مما يساعد في التشخيص المبكر والتخطيط العائلي.
2. How is the sample collected and what is the turnaround time?
A simple blood sample, extracted DNA, or one drop on an FTA card is collected at home by a certified phlebotomist; results arrive within 3 to 4 weeks. يتم جمع العينة عن طريق سحب الدم منزليًا أو بطاقة DNA FTA، وتظهر النتائج خلال 3 إلى 4 أسابيع.
3. Is this covered by insurance in the UAE?
We offer direct billing verification via WhatsApp at +971 54 548 8731 to check your insurance coverage for genetic testing. نوفر خدمة التحقق من تغطية التأمين الصحي للفحوصات الجينية مباشرة عبر الواتساب على الرقم +971 54 548 8731.
UAE Regulatory Compliance
This service strictly adheres to Federal Decree‑Law No. 41 of 2024 (Art. 87) regarding genetic testing consent, the CDS Law 2026 for minors, and the UAE Personal Data Protection Law (PDPL). Laboratory operations are certified to ISO 9001:2015 (Cert: INT/EGQ/2509DA/3139). All genetic data remains confidential; results are released only to the authorized physician and patient.
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians